Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD)

NCT ID: NCT00674895

Last Updated: 2009-01-05

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: PHASE1
• Total Enrollment: 10 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2008-05-31
• Study Completion Date: 2010-06-30

Brief Summary

Parkinson's disease (PD) is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills and speech. This study will investigate the use of far infrared radiation to manage, control and treat PD.

Detailed Description

Parkinson's disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement. The primary symptoms are the results of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. PD is both chronic and progressive.

Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells.

It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have PD.

Conditions

Parkinson's Disease

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

1

Radiation: Far Infrared Radiation (5μm to 20μm wavelength)

Group Type: EXPERIMENTAL

Far Infrared Radiation (5μm to 20μm wavelength)

Intervention Type: RADIATION

Radiation: Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.

Interventions

Far Infrared Radiation (5μm to 20μm wavelength)

Radiation: Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.

Intervention Type: RADIATION

Other Intervention Names

Far Infrared Radiation

Eligibility Criteria

Inclusion Criteria

• People with Parkinson's Disease

Exclusion Criteria

• None

• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

GAAD Medical Research Institute Inc.

OTHER

Sponsor Role: lead

Responsible Party

GAAD Medical Research Institute Inc.

Principal Investigators

Ken Nedd, M.D.

Role: PRINCIPAL_INVESTIGATOR

GAAD Medical Research Institute Inc.

Locations

The Centre for Incurable Diseases

Toronto, Ontario, Canada

Countries

Canada

Other Identifiers

GAAD-PD-CTP1

Identifier Type: -

Identifier Source: org_study_id